UroGen Pharma Ltd.
URGN
$29.80
-$1.53-4.88%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 140.27M | 120.46M | 127.03M | 156.95M | 195.89M |
| Total Receivables | 55.41M | 33.08M | 19.70M | 19.65M | 19.64M |
| Inventory | 20.92M | 16.46M | 8.34M | 7.13M | 7.59M |
| Prepaid Expenses | 19.53M | 14.67M | 12.12M | 12.06M | 12.98M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.33M | 1.35M | 1.35M | 1.08M | 1.08M |
| Total Current Assets | 237.46M | 186.02M | 168.55M | 196.87M | 237.18M |
|
|
|||||
| Total Current Assets | 237.46M | 186.02M | 168.55M | 196.87M | 237.18M |
| Net Property, Plant & Equipment | 8.56M | 9.09M | 9.18M | 6.24M | 5.38M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.67M | 5.34M | 6.94M | 978.00K | 547.00K |
| Total Assets | 253.69M | 200.46M | 185.05M | 208.72M | 247.62M |
|
|
|||||
| Total Accounts Payable | 17.21M | 12.14M | 10.28M | 13.56M | 14.57M |
| Total Accrued Expenses | 27.97M | 29.10M | 27.01M | 29.04M | 22.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.92M | 1.76M | 1.59M | 1.55M | 1.41M |
| Total Finance Division Other Current Liabilities | 3.54M | 3.43M | 3.37M | 3.39M | 3.30M |
| Total Other Current Liabilities | 3.54M | 3.43M | 3.37M | 3.39M | 3.30M |
| Total Current Liabilities | 50.64M | 46.42M | 42.24M | 47.55M | 42.00M |
|
|
|||||
| Total Current Liabilities | 50.64M | 46.42M | 42.24M | 47.55M | 42.00M |
| Long-Term Debt | 189.53M | 122.21M | 122.11M | 122.51M | 122.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.65M | 6.12M | 6.24M | 3.41M | 2.84M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 132.13M | 131.18M | 129.86M | 128.62M | 127.13M |
| Total Liabilities | 377.94M | 305.93M | 300.45M | 302.09M | 294.08M |
|
|
|||||
| Common Stock & APIC | 859.03M | 854.22M | 817.92M | 806.62M | 803.59M |
| Retained Earnings | -983.29M | -959.72M | -933.35M | -900.01M | -850.07M |
| Treasury Stock & Other | 8.00K | 19.00K | 23.00K | 6.00K | 14.00K |
| Total Common Equity | -124.25M | -105.47M | -115.41M | -93.38M | -46.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -124.25M | -105.47M | -115.41M | -93.38M | -46.46M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -124.25M | -105.47M | -115.41M | -93.38M | -46.46M |
|
|
|||||